Real World Evidence Market

  • Published on 2025-11-11
  • Report Code: 437
  • 170-350 pages
Real World Evidence Market

Real World Evidence Market Segments: By Component (Claims Data, Clinical Settings Data, Patient-Powered Data, Pharmacy Data and Others); By End User (Healthcare Payers, Healthcare Providers, Pharmaceutical & Medical Device Companies and Others); By Therapeutic Area (Oncology, Immunology, Neurology, Cardiovascular Disease and Others) and Region - Global Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2030

Table Of Content

Contents          

  1. Executive Summary
  2. Global Real World Evidence Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Real World Evidence Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Real World Evidence Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Real-World Evidence: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa) By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Component: Market Share (2020-2030F)
      1. Claims Data, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Clinical Settings Data, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Patient-Powered Data, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Pharmacy Data, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By End-User: Market Share (2020-2030F)
      1. Healthcare Providers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2020-2030
      2. Pharmaceutical & Medical Device Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Therapeutic Area: Market Share (2020-2030F)
      1. Oncology, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Immunology, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Neurology, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Cardiovascular Disease, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Other Solutions, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13.  Company Profile

  1. IQVIA
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. IBM Corporation
  3. Cognizant
  4. Oracle Corporation
  5. Syneos Health
  6. Pharmaceutical Product Development
  7. Clinigen Group plc
  8. PAREXEL International Corporation
  9. Palantir Technologies
  10. SAS
  11. Other Prominent Players

Consultant Recommendation

The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients